The biomanufacturing viral detection and quantification market is driven by the increasing complexity of biologics, rising ...

Moderna and Alnylam are investing millions in Massachusetts biomanufacturing, a rare win for a state often losing the ...

TEDCO issued a $1 million grant to help build the state’s first fully integrated algae-based biomanufacturing facility in Aberdeen.

Maryland's 1st fully integrated algae-based biomanufacturing facility in Aberdeen has received a $1M award to use for upgrades, expansion.

With six drugs approved for commercial development, Cambridge-based drugmaker Alnylam Pharmaceuticals Inc. is investing $250 ...

Biopharmaceutical companies take on a lot of risk developing new large molecule drugs. With more complex molecules in development, changing capacity needs, uncertain forecasts and increased ...

As of midyear, Maryland’s biomanufacturing footprint had a 1.1% vacancy rate, while its R&D footprint sat at 10.8% vacant, ...

Manufacturing facilities that make the next generation of drugs and therapeutics are seeing a burst of interest across the country, rising from their former status as a niche subset of life sciences ...

Recent funding round, led by Hudson Bay Capital, fuels expanded capacity and commercialization of formulated intermediates across oil & gas, mining, agriculture and industrial & CPG markets SOLON, ...

Three universities join with industry to give graduates the skills and knowledge needed to scale up the benefits of ...

New York, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Next-Generation Biomanufacturing Market - A Global Analysis: Focus on Single-Use and Digital Platform ...